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ABSTRACT 
The Efficacy of a Lactic Acid Bacteria Treatment to Inhibit Escherichia albertii on Ground 
Chicken. (May 2014) 
 
Thomas Jeffry Tschirhart 
Department of Biology 
Texas A&M University 
 
Research Advisor: Dr. T. Matthew Taylor 
Department of Animal Science 
 
Escherichia albertii has recently become a challenge to food safety.  The organism has been 
mistakenly identified as Hafnia alvei, a member of the pathogenic Escherichia coli and others.  
Early last year, a foodborne disease outbreak in Japan identified E. albertii as the causative 
agent.  Lactic Acid Bacteria (LAB) can be used as a natural antimicrobial applied to foods to 
inhibit the growth of pathogenic microorganisms.  To date, no significant research has been 
performed as to whether the LAB have any effect on foods inoculated with E. albertii.  
Therefore, the objective of this experiment was to determine the efficacy of treatment of E. 
albertii with LactiGuard™, a natural LAB treatment currently being employed in the food 
processing industry to increase food safety.  If successful, this will indicate that LactiGuard™ is 
an intervention treatment that can be used to control the growth of E. albertii on cross-
contaminated poultry. 
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NOMENCLATURE 
 
ANOVA    Analysis of Variance 
ATCC    American Type Culture Collection, Manassas, Virginia 
CFU    Colony Forming Unit 
E. albertii    Escherichia albertii 
E. coli     Escherichia coli 
H. alvei   Hafnia alvei 
LAB      Lactic Acid Bacteria 
lbs     Pounds 
log10    Logarithm (Base 10) 
MRS     deMan, Rogosa, and Sharpe Lactobacilli agar 
RR-MAC  MacConkey agar supplemented with 0.1 grams/liter Rifampicin 
and 10 grams/liter L-Rhamnose 
TSA-R    Tryptic Soy Agar supplemented with 0.1 grams/liter of Rifampicin 
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CHAPTER I 
INTRODUCTION 
 
In 1990, a diarrheal sample containing Escherichia albertii was obtained from a nine month old 
girl and isolated at the International Center for Diarrhoeal Disease Research (ICCDR) in 
Bangladesh.  The pathogen contained within the stool samples was originally identified as 
Hafnia alvei due to presumptive identification along with H. alvei being the only organism 
isolated from the child (7).  Further research by Albert and others (8) led to the discovery that the 
organism produced attaching and effacing (A/E) lesions that were genetically similar to those 
produced by enteropathogenic Escherichia coli (EPEC).  This discovery more closely aligned the 
organism, thought to be H. alvei, with the enteropathogenic E. coli.  Genetic testing showed that 
E. albertii possessed enough genetic differentiation in its genome, compared to E. coli, to be 
named as a new species under the genus Escherichia, resulting in the suggestion of Escherichia 
albertii, named for M.J. Albert, the leader of the group originally isolating and identifying the 
pathogen (4).  The naming of a new species naturally attracted many researchers to further 
identify the organism.  Abbott and others (1) found that E. albertii was not able to ferment D-
sorbitol, a trait that is typically closely associated with some strains of E. coli.  It was later found, 
through genetic typing of the 16s RNA sequence, that E. albertii is most closely related to 
Shigella boydii not E. coli (6). 
 
Recently, E. albertii was identified as the causative agent of an outbreak of foodborne disease in 
Japan where 31 people became ill with diarrhea, fever and abdominal pain (11).  Although it is 
not known what food acted as the transmission vehicle for the outbreak, the outbreak has been 
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traced back to a restaurant in Japan where it has been theorized that the food became 
contaminated at some point in the preparation process.  From this outbreak, Ooka and others (11) 
recovered 26 E. albertii isolates, 13 from symptomatic humans, that had been previously 
misidentified as EPEC.  Previous international research by Ooka and others (10) found that the 
cause of around 9.4% of foodborne illnesses may be misdiagnosed in the laboratory setting 
because of the similarity of E. albertii to other more well-known gastrointestinal pathogens such 
as E. coli O157:H7.  Although it is not known what caused the outbreak in Japan, there is much 
concern regarding whether avian species are a potential vector of the infectious agent (9). Young 
and others (9) found that wild birds can carry E. albertii and can be a potential source of 
infections in humans.  Clearly, E. albertii is an under-researched pathogenic microbe whose 
prevalence is mostly unknown due to its lack of epidemiological data and misidentification.  This 
has contributed significantly to a lack of research on food intervention treatments targeting E. 
albertii. 
 
The Centers for Disease and Prevention (CDC; Atlanta, GA) estimates that 9.4 million cases of 
foodborne illness occur in the United States every year from major pathogens, where roughly 
1,351 of these cases result in death of the consumer and 64% of these deaths are caused by 
bacteria alone (14).  Estimates of all foodborne illnesses in the United States annually approach 
48 million cases (14).  Scharff and others (15) used these same estimates to conclude that 
foodborne illnesses account for $77.7 billion in annual health-related costs.  It is worth noting 
that of all food commodities produced in the United States, poultry products account for the 
majority (19%) of all food related deaths (12).  This leads to a problem when considering today’s 
health mindset where consumers desire a healthier food product, usually poultry, treated with 
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more natural antimicrobials.  Common poultry treatments in today’s processing plants includes 
varying chemical washes or sprays such as acidified sodium chlorite or cetylpyridinium chloride.  
Natural preservative include the use of plant based preservatives, garlic and bacteria. 
 
The Lactic Acid Bacteria (LAB) have been known to compete for attachment sites and resources 
with other microbes and, in some cases, their waste products hinder or inactivate certain bacteria 
(3).  LAB were first studied due the inhibitory effect of nisin, a bacteriocin produced by 
Lactobacillus lactis (2).  This bacteriocin is ideal for use because it created by a nonpathogenic 
organism and is easily digested by humans.  Lactic acid and other products produced by LAB 
have been used to lower the pH and have been found to be effective (5).  To date, no research has 
been conducted with the aim of testing whether LAB will have any effect on E. albertii in any 
food product.  The purpose of this experiment was to determine LactiGuard™ would produce any 
statistically significant change in E. albertii cell counts inoculated onto ground chicken products 
during refrigerated storage.  LactiGuard™ is a natural antimicrobial consisting of four non-
pathogenic microbes, which are known to antagonize foodborne pathogens: Lactobacillus 
acidophilus (LA51), Lactobacillus lactis (NP7), Pediococcus acidilactici (D3) and Lactobacillus 
animalis (NP28).  The efficacy of spraying LAB on E. albertii can determine the usefulness of 
using LAB as a step in food processing to reduce prevalence of E. albertii.   
 
The research hypotheses to be tested are H₀: the application of LAB will not show a statistically 
significant reduction of E. albertii on inoculated ground chicken, and; H₁: application of LAB 
onto E. albertii inoculated chicken will produce a significant reduction in the ability of E. 
albertii to reproduce. The hypotheses will be confirmed or rejected based on Analysis of 
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Variance (ANOVA) of experimental results from experiments enumerating surviving E. albertii 
on ground chicken meat inoculated with the pathogen and treated with the LAB antimicrobial 
(p<0.05). 
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CHAPTER II 
METHODS 
 
Preliminary trials methodology 
Growth curve 
Three strains of rifampicin resistant E. albertii (ATCC 19982, 9194 and 10457), obtained from 
the Department of Animal Science Food Microbiology Laboratory, were resuscitated from 
cryogenic beads by making two successive transfers into 9.0 mL TSB (Becton, Dickinson and 
Company., Spark, Maryland) for incubation at 35°C for 24 hours.  After revival, the E. albertii 
strains were streaked on TSA (Becton, Dickinson and Company., Spark, Maryland) plus 0.1g/L 
rifampicin (Sigma Aldrich., St. Louis, Missouri) to ensure antibiotic resistance.  Colonies from 
each plate/strain were aseptically transferred to slants of TSA with an overlay of mineral oil for 
storage in the refrigerator (5°C). 
 
Two days before the trial was initiated the E. albertii cells were revived via two successive 
subcultures in TSB for 24 hours each at 35°C.  The cells were then washed twice by adding 9 mL 
of 0.9 % NaCl (Becton, Dickinson and Company., Spark, Maryland)  following centrifugation at 
2209 RCF for 15 minutes.  The cell cultures were serially diluted (10 fold) six times where the 
final dilution was into 99 mL of TSB (100 fold).  Samples were then taken at 0, 1, 2, 4, 6, 8, 10, 
12 and 24 hours for dilution and plating on TSA.  The 0 and 24 hour time points were also plated 
on RR-MAC. 
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Achieving target application of LactiGuard™ 
The first preliminary trial was run to determine the concentration of inoculum and sprays needed 
to reach 10
6
 CFU/g of LactiGuard™ on chicken.  The four isolates of Lactic Acid Bacteria 
(LAB): Lactobacillus lactis, Lactobacillus animalis, Lactobacillus acidophilus and Pediococcus 
acidilactici, were revived by aseptically adding 1 gram of each isolate to individual 99 mL 
bottles of 0.1% (w/v) peptone (Becton, Dickinson and Company., Spark, Maryland).  After 
shaking vigorously each bottle, 10 mL of each isolate were combined together in a 50 mL 
conical tube.  One milliliter of this cocktail solution was added to 9 mL of 0.9% (w/v) NaCl.  
One milliliter of this diluted solution was then added into 99 mL of NaCl which was 
subsequently added into a plastic spray bottle, obtained from a College Station, TX, retail grocer, 
for application. 
 
Raw chicken trimmings were obtained from the Department of Poultry Science, Texas A&M 
University, College Station, TX, for this experiment.  Upon arrival to the Food Microbiology 
Laboratory, chicken trimmings were stored at -18°C until needed.  Two days before use, the 
chicken trim was set in the 5°C cold room to thaw.  After 24 hours, the chicken trim was taken 
out of the cold room and aseptically weighed into four distinct samples each totaling 250 grams, 
after which the chicken aliquots were placed back in the cold room.  One sample served as the 
negative control, to determine the background LAB present in the chicken.  The other three 
samples were sprayed (1.6 mL/spray) with LactiGuard™ (roughly 9.2 log10 CFU/mL) either one, 
two or three times followed by homogenization of the treatment by hand massaging for 1.0 
minutes.  After massaging, three 25.0 g aliquots of each sample were removed for serial dilution 
(10 fold) in 0.9% NaCl and were plated on MRS (Becton Dickinson and Company., Sparks, 
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Maryland).  The trial was replicated three times (n=3) and plate counts of organisms were 
converted into log₁₀ for statistical analysis. 
 
Inoculation of chicken trimming with E. albertii 
Two days before the experiment was initiated the E. albertii strains were revived from the slants 
by two successive sub-cultures, the first of which occurred in 9 mL TSB.  The second transfer 
was completed in a 50 mL conical tube containing 45 mL of TSB with phosphate added to the 
amount of 4 g/L total phosphate in solution.  The phosphate has been added to ensure that the 
bacteria do not become acid resistant during incubation, from acid waste buildup, due to the acid 
fermentation of glucose present in the medium.  After incubation for 24 hours, the conical tubes 
will be centrifuged for 15 minutes at 2209 RCF.  The supernatant will be poured off so the cells 
can be re-suspended in 45 mL of 0.9% NaCl.  After re-suspension the third time, 15 mL from 
each tube will be transferred into two sterile 50 mL conical tube.  These 45 mL cocktails will be 
centrifuged and re-suspended following the same procedure as above.  Two distinct bottles of 
inoculum solution were prepared.  The first bottle was prepared by adding all 45 mL of cocktail 
into 405 mL NaCl creating a 10
8
 CFU/ml solution.  The second bottle was made by adding 4.5 
mL of cocktailed solution into 445.5 mL of NaCl creating a 10
7
 CFU/mL solution.  Chicken 
trimming was obtained, thawed and weighed in the same method as stated previously where only 
three 300 gram aliquots were prepared.  One sample acted as the negative control and was used 
to determine if background organisms resistant to rifampicin were present.  Chicken inoculation 
was achieved by pouring each bottle into their respective bags for submersion totaling 1.0 
minutes.  The chicken was allowed to dry for one minute.  Two 25 gram aliquots were taken and 
serially diluted followed by plating on TSA-R.  The remaining 250 grams of each sample were 
12 
 
ground with a 10 mm plate producing a coarse ground chub, after which two additional 25 gram 
aliquots were diluted and plated.  The negative control was sampled before and after grinding 
following the same method.  The trial was replicated three times (n=3) and plate counts of 
organisms were converted into log₁₀ for statistical analysis. 
 
Experimental methodology 
Preparation of inoculum solution 
The preparation of the inoculum solution followed the same protocol as the preliminary trial 
concerned with E. albertii application.  Changes to be made are that only one 45 mL cocktailed 
solution is to be made and 0.9 ml of the re-suspended cocktail will be added to four bottles 
containing 899.1 ml of 0.9% NaCl totaling 900 mL of inoculating solution per bottle. 
 
Preparation of treatments 
The four isolates of Lactic Acid Bacteria (LAB) were revived by aseptically adding 1 gram of 
each isolate to individual 99 mL bottles of 0.1% peptone.  After mixing each bottle, 10 mL of 
each isolate were mixed together in a 50 mL conical tube.  Ten milliliters of this cocktail solution 
was added to 90 mL of NaCl which was subsequently added into a plastic spray bottle, obtained 
from a College Station, TX, retail grocer, for application.  The change in dilution from the LAB 
preliminary trial was due to problems encountered concerning differences in sample weight and 
loss of cells during the increased drying times. 
 
The peracetic acid treatment was prepared by adding 15 mL peracetic acid concentrate to 485 
mL distilled water for an application concentration of 700 ppm.  The solution was then placed in 
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a similar spray bottle for application.  The peracetic acid was applied according to 
manufacturer’s guidelines.  The verification of concentration was achieved using the test kit 
provided by FMC.  Ten milliliters of the solution to be tested were placed in a tube where 10 
drops of sulfuric acid and one drop potassium iodide were added.  Peracetic acid titrant was 
added on a dropwise basis with swirling of the solution following each added drop.  The drops 
were added until a change in the solution’s color was observed.  The number of drops added was 
multiplied by 15 yielding the concentration in the original solution. 
 
Preparation of chicken 
Raw Chicken trimming was obtained from the same source as the preliminary trials.  The same 
storage and aliquoting procedures from the preliminary trials were used.  The first sample 
weighed served as the negative control and weighed 350 grams.  The negative control was not 
inoculated with pathogen or treated with a food intervention agent and was used to determine the 
background LAB and possible antibiotic resistant organisms.  The second sample will be treated 
with E. albertii inoculum and will weigh roughly 1050 grams.  The separated samples were then 
placed back in the cold room for use the next day.  The next day, the chicken from sample two 
was submerged in a 3.6 liter volume of E. albertii at a concentration of 10
6
 CFU/mL for 1.0 
minutes.  The inoculated trimming was then allowed to set for 30 minutes (also allowing for 
bacterial attachment to meat surfaces) and then separated to dry into three 350 gram portions.  
One of the inoculated chicken portions was sprayed with Lactiguard™ to a target of 106 CFU/g 
and allowed to dry for 30 minutes.  A second 350 gram portion of the inoculated chicken will be 
sprayed with peracetic acid and allowed to dry for 30 minutes.  All the chicken samples were 
then ground in a grinder, with a plate size of 10 mm producing a coarse ground chub, and the 
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newly ground chicken was placed in the cold room.  The ground chicken from each sample was 
then separated into ten 30 gram portions.  Each portion was wrapped with saran wrap to model 
market conditions.  Two 30 gram samples from each treatment were removed and subjected to 
serial dilution for plating on days 0, 1, 3, 5 and 7.  The negative control was plated on MRS to 
determine the amount of background LAB.  The positive control was plated on TSA-R along 
with the peracetic acid treated sample.  The Lactiguard™ treated samples were plated on both 
TSA-R and MRS*.  The MRS* was used for selective plating of LactiGuard constituent 
organisms and was supplemented with a series of antimicrobials protected under non-disclosure 
agreement with the intervention supplier (Nutrition Physiology Corp., Overland Park, KS). 
 
Statistical analysis and experimental replication and design 
The experiment was replicated two times (n=2) and plate counts of organisms were converted 
into log₁₀ for statistical analysis. Data were assumed to adhere to a normal distribution and 
significantly different means were identified by one-way analysis of variance (ANOVA), with 
means being separated via Tukey’s Honestly Significant Differences (HSD) test at p=0.05. All 
statistical analysis was completed using JMP v.11.1.1 (SAS Institute, Inc., Cary, NC). 
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CHAPTER III 
RESULTS 
 
Preliminary results 
Determining growth after 24 hours 
The results in Figure 1 show that the E. albertii grew roughly 6.5 log10 CFU/mL over 24 hours of 
incubation at 35°C.  This data was used in later experiments to be able to approximate the 
amount of cells that are present in solution after incubation.  The lack of uniformity at later 
sampling time may be attributed to sampling and plating error. 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Growth curve of three E. albertii strains over 24 hours.  A growth curve with 
triplicate means of three E. albertii strains is shown with data being taken at hours 0, 1, 2, 4, 6, 8, 
10, 12 and 24. 
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Application of LactiGuard™ 
The negative control was plated on MRS to determine background LAB.  Colony counts were 
within the acceptable range for normal background LAB present in poultry samples (Data not 
shown).  The LactiGuard inoculum was found to total to roughly 9.2 log10 CFU/mL (Data not 
shown).  The results of the treated samples indicate that three sprays of LactiGuard™ inoculum 
most closely approached the 6.0 log10 CFU/g application limit set by the USDA-FSIS (Figure 2).  
In the final trial, an addition chicken sample was sprayed four times but subsequent attachment 
numbers did not differ significantly from three sprays (Data not shown).   
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Mean attachment of LAB on poultry as a function of number of sprays.  Bars 
depict mean attachment from triplicate identical replicates (n=3).  Error indicate one SD from the 
mean. 
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Inoculation of poultry trimming with E. albertii 
The negative control in this experiment was plated on TSA-R to determine background 
resistance to rifampicin.  No resistance was found pre or post grind in all three replicates (Data 
not shown).  Figure 3 depicts the attachment numbers of E. albertii pre and post grinding when 
applied at inoculum concentrations of either 10
8
 or 10
7
 CFU/mL.  The data from this trial was 
used to create the inoculum solution for the experiment by further diluting the experimental 
inoculum to 10
6
 CFU/mL.  This would result in roughly 4.0 log10 CFU/g E. albertii attachment 
on the experimental chicken.  
 
 
 
 
 
 
 
 
 
 
Figure 3. The attachment numbers of E. albertii applied at varying concentrations before 
and after grinding.  Bars on the left depict E. albertii attachment number pre grind while bars 
on right depict attachment numbers post grind of triplicate identical replicates (n=3).  Error bars 
depict one SD from the mean. 
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Experimental results 
The negative control was plated on both TSA-R and MRS* to determine background antibiotic 
resistance.  No background microbes bearing resistance to rifampicin were recovered on TSA-R 
surfaces.  Conversely, multiple colonies on MRS* from non-treated meat samples were 
recovered on MRS*, indicating background LAB capable of resisting the antibiotics, thus 
indicating lack of strong selective capacity of MRS* for selective recovery of LactiGuard™ (Data 
not shown).  The results of the treated samples indicate that neither LactiGuard™ or peracetic 
acid treatment produced any significant inhibitory effect on E. albertii, or its survival on poultry 
meat (Figure 4).  Statistical analysis of gathered data indicated that duration of sample incubation 
was not significant in its effect on E. albertii survival or inhibition (p>0.05) (Data not shown).  
Although the LactiGuard™-treated samples had a higher number of E. albertii survivors, this 
would be attributable to inherent sampling and plating variability and/or lack of reproducibility.  
Over seven days, the numbers of E. albertii cells did decrease but compared to the control these 
decreases were not a result of treatment.  Perez and others (13) found that E. albertii, when 
placed under refrigeration conditions, will slowly die over time.  Smith and others (16) found 
that, under similar treatment and storage conditions, E. coli and Salmonella were reduced by 2.0-
3.0 log10-cycles in a beef matrix. It is possible that the chicken could have caused reduced 
LactiGuard™ efficacy due to differences in nutritional make-up of the chicken matrix as 
compared to beef. Additionally, Smith and others (16) were able to treat their beef samples to 10
8 
CFU/g due to differences in USDA-FSIS allowances between chicken and beef. Further, given 
the inoculation of trimmings and treatment with LactiGuard™ prior to grinding, the opportunity 
for dispersion of cells through grinding may have led to insufficient numbers of LAB contacting 
pathogens for inhibition to be observed.  
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Figure 4. Least square means of E. albertii survival on poultry meat as a function of 
antimicrobial treatment. Bars depict LS means from duplicate identical replicates (n=2). LG = 
LactiGuard™ 6.0+ 0.1 log10 CFU/g inoculum; PAA = peracetic acid (700 ppm). Bars not sharing 
letters differ at p<0.05. 
 
 Figure 5 shows the growth of LactiGuard™ on poultry inoculated with E. albertii over the seven 
day storage period.  The LactiGuard™ was applied at 106 CFU/g on day zero, but over seven 
days the cells increased to 10
7
 CFU/g.  This growth can be attributed to the psychrophilic 
qualities of the cocktailed isolates.  This growth can have severe consequences in an industry 
setting due to USDA-FSIS application guidelines stating that LAB treatments can only be 
applied on poultry to a total of 10
6
 CFU/g.  A future experiment of the efficacy of LactiGuard™ 
on E. albertii would benefit from being carried out on a beef food matrix so that results from 
Smith et al. will be more useful. 
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Figure 5. Inoculation and increase in numbers of LactiGuard™ on E. albertii-inoculated 
poultry meat at 5°C. Symbols indicate means of duplicate identical replications (n=2); errors 
bars indicate one sample standard deviation. LactiGuard™ were enumerated on MRS agar 
supplemented with proprietary antibiotic mixture. 
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CHAPTER IV 
CONCLUSIONS 
 
The purpose of this study was to determine the efficacy of a LAB treatment to inhibit E. albertii 
inoculated chicken.  E. albertii is a foodborne pathogen that is resistant to some common 
biological and chemical preservative methods employed by the poultry industry.  Hopefully, 
future studies will be able to provide insight into why E. albertii is more resistant to the 
fermentative byproducts of LAB.  This may provide a novel testing method to allow for easier 
differentiation between E. albertii and the closely related E. coli.  LactiGuard™ as a food 
intervention step to inhibit E. albertii may have better efficacy when applied on carcasses or in a 
post grind setting. 
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